Health Care

Pfizer net plunges 38 pct., misses Street 3Q forecasts

Drugmaker Pfizer topped off a difficult third quarter with news that it's scrapping a closely watched experimental cholesterol drug, partly due to expectations insurers would limit access so much that it wouldn't make much money, a possible bad omen for the pharmaceutical industry.

Health Law Enrollment Opens Amid Volatility

The fourth open enrollment for health coverage under the Affordable Care Act opened Tuesday, a critical 90 days that the Obama administration hopes will boost participation and stabilize markets roiled by premium increases and insurer withdrawals.

Pfizer Cuts Outlook, Shares Fall

Pfizer on Tuesday lowered its earnings outlook for the year and said it was ending the development of a drug in the massive cholesterol-treatment sector.

Despite warnings, extremely dangerous air bags not repaired

Owners of more than 300,000 Hondas have yet to get their air bags repaired, despite warnings from the automaker and regulators that the inflators have an extremely high chance of rupturing and causing injury or even death.

Mylan Executives Unlikely to Lose Pay Over EpiPen Issue

Executives of EpiPen maker Mylan NV are unlikely to suffer a reduction in their pay from the company's recent $465 million settlement of allegations that it improperly overcharged Medicaid for the lifesaving drug.

Aetna's 3Q Earnings Rise 8%

Aetna, No. 3 U.S. health insurer, reported an 8 percent rise in quarterly profit as memberships grew in its government business, which sells Medicaid and Medicare plans.